Laboratory tests in primary care · by Dr Solange Déplanque and Dr Michaël Rochoy

Chronic breathlessness in adults: first-line tests

Respiratory medicine and allergy · Symptom or situation · updated 2026-10-31

BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.

Frequency: In general adult populations of high-income countries, the prevalence of dyspnoea (all definitions) is 10% (95% CI 7-15), with marked heterogeneity depending on the definition [1].

Breathlessness for more than one month

In the practice and imaging

Laboratory tests

Detailed explanation and international comparison (in French): read it in English (machine translation)

Also consider

Sources (7)
  1. Müller A, Mraz T, Wouters EFM, van Kuijk SMJ, Amaral A, et al. Prevalence of dyspnea in general adult populations: a systematic review and meta-analysis. Respir Med 2023;218:107379.
  2. National Institute for Health and Care Excellence (NICE). Chronic heart failure in adults: diagnosis and management. Guideline NG106, septembre 2018, mise à jour 3 septembre 2025.
  3. Budhwar N, Syed Z. Chronic dyspnea: diagnosis and evaluation. Am Fam Physician. 2020;101(9):542-548.
  4. National Institute for Health and Care Excellence (NICE). Chronic obstructive pulmonary disease in over 16s: diagnosis and management. Guideline NG115, décembre 2018, mise à jour juillet 2019.
  5. Haute Autorité de santé. Guide du parcours de soins « Insuffisance cardiaque ». Février 2012, actualisé en juin 2014.
  6. NHS England. Adult breathlessness pathway (pre-diagnosis): diagnostic pathway support tool. 26 avril 2023, mise à jour du 4 mai 2023.
  7. Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale VersorgungsLeitlinie Chronische Herzinsuffizienz, Langfassung, Version 4.0, 2023.